Jan 29, 2021 11:33am EST Greenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment Option
Jan 29, 2021 6:00am EST Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money Report
Jan 21, 2021 6:00am EST Greenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor Conferences
Jan 08, 2021 6:00am EST Greenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021 JP Morgan Healthcare Week
Dec 22, 2020 10:12am EST Greenwich LifeSciences, Inc. Announces Closing of Public Offering of Common Stock
Dec 18, 2020 6:00am EST Greenwich LifeSciences, Inc. Prices $26.4 Million Upsized Public Offering of Common Stock
Dec 15, 2020 6:00am EST Greenwich LifeSciences Announces Option Agreement for Pre-clinical Coronavirus Vaccine Candidates
Dec 11, 2020 6:00am EST Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer